相关实验视频

Updated: Jan 17, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.1K

综合性单细胞和机器学习分析预测前列腺癌中乳酸驱动疗法耐药性:一种分子对接和实验验证的治疗优化框架

Zhiyu Liu1,2, Yuqi Li1,2, Juan Wang1

  • 1Department of Urology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.

Frontiers in immunology
|September 18, 2025
PubMed
概括

使用乳化和耐药性生物标志物的新模型可以准确预测前列腺癌的预后和治疗反应. 这种工具有助于个性化医疗,并改善患者风险分层.

关键词:
生物标志物 生物标志物药物耐药性 耐药性 药物耐药性乳化 乳化 乳化机器学习是机器学习.前列腺腺腺癌前列腺腺腺癌.一个单细胞测序.

更多相关视频

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses08:36

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

11.7K
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

13.9K

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K